Rhythm

PINNACLE FLX Study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device Presented as Late-Breaking Clinical Trial at HRS 2020 SCIENCE

Trial meets primary safety and efficacy endpoints with low complication rates, 100% effective closure with next-generation stroke risk reduction technology for patients with non-valvular atrial fibrillation MARLBOROUGH, Mass., May 8, 2020 /PRNewswire/ — Today, Boston Scientific (NYSE: BSX) announced positive 12-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy […]

Thermedical Announces SERF VT Study Presented as Part of HRS 2020 Science Late-Breaking Clinical Trial Sessions

Results Suggest Highly Effective Method to Treat Ventricular Tachycardia, a Leading Cause of Sudden Cardiac Death WALTHAM, Mass.–(BUSINESS WIRE)–Thermedical®, a developer of thermal-ablation systems to treat ventricular tachycardia (VT), announced that results from a First-in-Human Early Feasibility Study (EFS) using the new Durablate® catheter to treat VT were presented in […]

AtriCure Announces Results from CONVERGE IDE Clinical Trial

Results presented virtually via Heart Rhythm 365 Platform; study met primary effectiveness endpoint of superiority in favor of the hybrid Convergent procedure MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced the results from the CONVERGE […]

Real-World Data Validating BeatLogic® Deep Learning Platform for Comprehensive ECG Interpretation Through Remote Cardiac Monitoring Published in Heart Rhythm

Study Shows Accuracy of Deep Learning in Interpreting Multiple Levels of Remote Cardiac Monitoring Data MINNEAPOLIS, May 7, 2020 /PRNewswire/ — Preventice Solutions announced the publication of real-world data further validating BeatLogic® deep learning models designed to detect and classify multiple levels of data on heart rhythms gathered using BodyGuardian® remote cardiac monitoring […]

Clinical Data Evaluating Gencaro for the Treatment of Atrial Fibrillation in Heart Failure Patients Featured in Three Presentations at the 2020 Heart Rhythm Scientific Sessions

New data provide additional evidence of efficacy for Gencaro compared to active control in a pharmacogenetically-defined HF population at risk for AF recurrence °  26% reduction in total time spent in AF (p < 0.001) °  30% decrease in AF interventions and cardiovascular adverse events (p = 0.008) °  55% lower incidence […]

PhysIQ, Department of Defense, and The Henry M. Jackson Foundation for the Advancement of Military Medicine Partner to Deploy Continuous Remote Monitoring Platform to Study COVID-19

This DOD-funded initiative will assess the role of home-based continuous biosensor data and AI analytics in addressing the global COVID-19 crisis. The program will initially involve military hospitals across the United States, as well as international sites in Southeast Asia. PhysIQ artificial intelligence systems to be used to collect data […]

AliveCor Partners with The Clifford Lab at Emory University and Georgia Institute of Technology

Collaboration will propel the development of new cardiovascular AI solutions MOUNTAIN VIEW, Calif., May 6, 2020 /PRNewswire/ — AliveCor, the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, announced a strategic collaboration with the Clifford Lab at Emory University School of Medicine, and the Georgia Institute of Technology (Georgia Tech). The Clifford Lab will […]

Fitbit Announces Large-Scale Study to Identify Atrial Fibrillation

Study part of broader Company efforts to make health tools more accessible and reduce the risk of life-threatening events like stroke SAN FRANCISCO–(BUSINESS WIRE)–Fitbit (NYSE: FIT) today launched the Fitbit Heart Study, its first large-scale, virtual study to validate the use of its wearable technology to identify episodes of irregular heart rhythm […]

FineHeart Completes First Successful Chronic In-Vivo Study of its ICOMS Device Intended for the Treatment of Severe Heart Failure

First destination therapy that restores natural heart pumping capacity; potential game changer for more than 200,000 untreated severe heart failure patients per year BORDEAUX, France–(BUSINESS WIRE)–FineHeart, a French medical device company, today announced the success of a seven-day preclinical study to evaluate its Implantable Cardiac Output Management System (ICOMS), the […]

LifeSignals Receives CE Mark Approval for LifeSignals ECG Remote Monitoring Patch Platform (LX1250E)

Continuous patient monitoring with remote data access in ambulatory, hospital and home settings enables faster clinical decision making FREMONT, California, May 5, 2020 /PRNewswire/ — LifeSignals, today announced the awarding of the CE (Conformité Européene) Mark for their LifeSignals ECG Remote Monitoring Patch – a disposable wireless remote monitoring system, intended for […]